High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation
Although there have been previous studies of deep-brain stimulation (DBS), we present, to our knowledge, the first example of high-frequency depressive severity measurement-based DBS treatment in particular and psychiatric treatment in general. Daily post-surgical e-mail prompts for a period of 6 mo...
Gespeichert in:
Veröffentlicht in: | Translational psychiatry 2017-08, Vol.7 (8), p.e1207-e1207 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e1207 |
---|---|
container_issue | 8 |
container_start_page | e1207 |
container_title | Translational psychiatry |
container_volume | 7 |
creator | Sani, S Busnello, J Kochanski, R Cohen, Y Gibbons, R D |
description | Although there have been previous studies of deep-brain stimulation (DBS), we present, to our knowledge, the first example of high-frequency depressive severity measurement-based DBS treatment in particular and psychiatric treatment in general. Daily post-surgical e-mail prompts for a period of 6 months resulted in 93 administrations of a computerized adaptive test (CAT) of depression severity (CAT-Depression Inventory or CAT-DI) via the internet. There was an average of 3.37 weekly measurements with an average separation of 2.12 days. No additional incentive was provided to the patient for completing the adaptive tests. The patient is a 55-year-old female with six psychiatric hospitalizations for depression, two suicide attempts, marginal response to eight electroconvulsive therapy (ECT) treatments and 35 psychotropic medications. We report results after high-frequency stimulation of the superolateral branch of the medial forebrain bundle. The CAT-DI was used for daily assessments before, during and after (remotely in response to an e-mail prompt) the DBS procedure. Two follow-up Hamilton Depression Scales (HAM-Ds) were also collected. Response to treatment varied markedly, with a decrease from severe (>75) to mild (60), which is three times the size of the uncertainty level. Although the HAM-D scores decreased, they missed the more complete temporal pattern identified by CAT-DI daily monitoring. We demonstrated feasibility of daily depressive severity measurement at high levels of precision and compliance. Clinician ratings confirm the general pattern of treatment benefit, but mask the marked variability in mood and more marked periods of benefit and decline. |
doi_str_mv | 10.1038/tp.2017.145 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5611718</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1929886826</sourcerecordid><originalsourceid>FETCH-LOGICAL-c446t-596bdc526578ab0fd669e024d1e59c390f02cf10994f4ecc51fda3143af386313</originalsourceid><addsrcrecordid>eNptkc9rHCEUgKU0NCHNqfci9FJoZqMzo6uXQglNUwjkkp7FdZ67hhmdqrNl_4f-0XWYJGxLvfjjfX4-30PoHSUrShpxlcdVTeh6RVv2Cp3VlImqoUK8PlqfoouUHkkZrBV0Td-g01oIIgWnZ-j3rdvuKhvh5wTeHPAAOk0RBvAZB4s7GCOk5PaAE-whunzAzmONR53dzOQIOkOHbYgLAcvRLKjKVZeyLtizJ3j8y-Vd2cNYbaIurpTdMPVFF_xbdGJ1n-DiaT5HP26-PlzfVnf3375ff7mrTNvyXDHJN51hNWdroTfEdpxLIHXbUWDSNJJYUhtLiZStbcEYRm2nG9o22jaCN7Q5R58X7zhtBuhMyTXqXo3RDToeVNBO_R3xbqe2Ya8Yp6WAogg-PgliKIVLWQ0uGeh77SFMSVFZSyG4qHlBP_yDPoYp-vK9mRJrThljhfq0UCaGlCLYl2QoUXOjVR7V3GhVGl3o98f5v7DPbS3A5QKkEvJbiEeP_sf3B1lTtlo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1928761555</pqid></control><display><type>article</type><title>High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Springer Nature OA Free Journals</source><source>Nature Free</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Sani, S ; Busnello, J ; Kochanski, R ; Cohen, Y ; Gibbons, R D</creator><creatorcontrib>Sani, S ; Busnello, J ; Kochanski, R ; Cohen, Y ; Gibbons, R D</creatorcontrib><description>Although there have been previous studies of deep-brain stimulation (DBS), we present, to our knowledge, the first example of high-frequency depressive severity measurement-based DBS treatment in particular and psychiatric treatment in general. Daily post-surgical e-mail prompts for a period of 6 months resulted in 93 administrations of a computerized adaptive test (CAT) of depression severity (CAT-Depression Inventory or CAT-DI) via the internet. There was an average of 3.37 weekly measurements with an average separation of 2.12 days. No additional incentive was provided to the patient for completing the adaptive tests. The patient is a 55-year-old female with six psychiatric hospitalizations for depression, two suicide attempts, marginal response to eight electroconvulsive therapy (ECT) treatments and 35 psychotropic medications. We report results after high-frequency stimulation of the superolateral branch of the medial forebrain bundle. The CAT-DI was used for daily assessments before, during and after (remotely in response to an e-mail prompt) the DBS procedure. Two follow-up Hamilton Depression Scales (HAM-Ds) were also collected. Response to treatment varied markedly, with a decrease from severe (>75) to mild (60), which is three times the size of the uncertainty level. Although the HAM-D scores decreased, they missed the more complete temporal pattern identified by CAT-DI daily monitoring. We demonstrated feasibility of daily depressive severity measurement at high levels of precision and compliance. Clinician ratings confirm the general pattern of treatment benefit, but mask the marked variability in mood and more marked periods of benefit and decline.</description><identifier>ISSN: 2158-3188</identifier><identifier>EISSN: 2158-3188</identifier><identifier>DOI: 10.1038/tp.2017.145</identifier><identifier>PMID: 28809861</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/378/340 ; 631/443 ; Behavioral Sciences ; Biological Psychology ; Deep Brain Stimulation ; Depressive Disorder, Treatment-Resistant - diagnosis ; Depressive Disorder, Treatment-Resistant - therapy ; Electroconvulsive therapy ; Female ; Humans ; Medial Forebrain Bundle - physiopathology ; Medicine ; Medicine & Public Health ; Middle Aged ; Neurosciences ; Original ; original-article ; Patient Compliance ; Pharmacotherapy ; Psychiatric Status Rating Scales ; Psychiatry ; Severity of Illness Index ; Telemedicine ; Treatment Outcome</subject><ispartof>Translational psychiatry, 2017-08, Vol.7 (8), p.e1207-e1207</ispartof><rights>The Author(s) 2017</rights><rights>Copyright Nature Publishing Group Aug 2017</rights><rights>Copyright © 2017 The Author(s) 2017 The Author(s)</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c446t-596bdc526578ab0fd669e024d1e59c390f02cf10994f4ecc51fda3143af386313</citedby><cites>FETCH-LOGICAL-c446t-596bdc526578ab0fd669e024d1e59c390f02cf10994f4ecc51fda3143af386313</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611718/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5611718/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,41120,42189,51576,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28809861$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sani, S</creatorcontrib><creatorcontrib>Busnello, J</creatorcontrib><creatorcontrib>Kochanski, R</creatorcontrib><creatorcontrib>Cohen, Y</creatorcontrib><creatorcontrib>Gibbons, R D</creatorcontrib><title>High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation</title><title>Translational psychiatry</title><addtitle>Transl Psychiatry</addtitle><addtitle>Transl Psychiatry</addtitle><description>Although there have been previous studies of deep-brain stimulation (DBS), we present, to our knowledge, the first example of high-frequency depressive severity measurement-based DBS treatment in particular and psychiatric treatment in general. Daily post-surgical e-mail prompts for a period of 6 months resulted in 93 administrations of a computerized adaptive test (CAT) of depression severity (CAT-Depression Inventory or CAT-DI) via the internet. There was an average of 3.37 weekly measurements with an average separation of 2.12 days. No additional incentive was provided to the patient for completing the adaptive tests. The patient is a 55-year-old female with six psychiatric hospitalizations for depression, two suicide attempts, marginal response to eight electroconvulsive therapy (ECT) treatments and 35 psychotropic medications. We report results after high-frequency stimulation of the superolateral branch of the medial forebrain bundle. The CAT-DI was used for daily assessments before, during and after (remotely in response to an e-mail prompt) the DBS procedure. Two follow-up Hamilton Depression Scales (HAM-Ds) were also collected. Response to treatment varied markedly, with a decrease from severe (>75) to mild (60), which is three times the size of the uncertainty level. Although the HAM-D scores decreased, they missed the more complete temporal pattern identified by CAT-DI daily monitoring. We demonstrated feasibility of daily depressive severity measurement at high levels of precision and compliance. Clinician ratings confirm the general pattern of treatment benefit, but mask the marked variability in mood and more marked periods of benefit and decline.</description><subject>631/378/340</subject><subject>631/443</subject><subject>Behavioral Sciences</subject><subject>Biological Psychology</subject><subject>Deep Brain Stimulation</subject><subject>Depressive Disorder, Treatment-Resistant - diagnosis</subject><subject>Depressive Disorder, Treatment-Resistant - therapy</subject><subject>Electroconvulsive therapy</subject><subject>Female</subject><subject>Humans</subject><subject>Medial Forebrain Bundle - physiopathology</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Middle Aged</subject><subject>Neurosciences</subject><subject>Original</subject><subject>original-article</subject><subject>Patient Compliance</subject><subject>Pharmacotherapy</subject><subject>Psychiatric Status Rating Scales</subject><subject>Psychiatry</subject><subject>Severity of Illness Index</subject><subject>Telemedicine</subject><subject>Treatment Outcome</subject><issn>2158-3188</issn><issn>2158-3188</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNptkc9rHCEUgKU0NCHNqfci9FJoZqMzo6uXQglNUwjkkp7FdZ67hhmdqrNl_4f-0XWYJGxLvfjjfX4-30PoHSUrShpxlcdVTeh6RVv2Cp3VlImqoUK8PlqfoouUHkkZrBV0Td-g01oIIgWnZ-j3rdvuKhvh5wTeHPAAOk0RBvAZB4s7GCOk5PaAE-whunzAzmONR53dzOQIOkOHbYgLAcvRLKjKVZeyLtizJ3j8y-Vd2cNYbaIurpTdMPVFF_xbdGJ1n-DiaT5HP26-PlzfVnf3375ff7mrTNvyXDHJN51hNWdroTfEdpxLIHXbUWDSNJJYUhtLiZStbcEYRm2nG9o22jaCN7Q5R58X7zhtBuhMyTXqXo3RDToeVNBO_R3xbqe2Ya8Yp6WAogg-PgliKIVLWQ0uGeh77SFMSVFZSyG4qHlBP_yDPoYp-vK9mRJrThljhfq0UCaGlCLYl2QoUXOjVR7V3GhVGl3o98f5v7DPbS3A5QKkEvJbiEeP_sf3B1lTtlo</recordid><startdate>20170815</startdate><enddate>20170815</enddate><creator>Sani, S</creator><creator>Busnello, J</creator><creator>Kochanski, R</creator><creator>Cohen, Y</creator><creator>Gibbons, R D</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20170815</creationdate><title>High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation</title><author>Sani, S ; Busnello, J ; Kochanski, R ; Cohen, Y ; Gibbons, R D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c446t-596bdc526578ab0fd669e024d1e59c390f02cf10994f4ecc51fda3143af386313</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>631/378/340</topic><topic>631/443</topic><topic>Behavioral Sciences</topic><topic>Biological Psychology</topic><topic>Deep Brain Stimulation</topic><topic>Depressive Disorder, Treatment-Resistant - diagnosis</topic><topic>Depressive Disorder, Treatment-Resistant - therapy</topic><topic>Electroconvulsive therapy</topic><topic>Female</topic><topic>Humans</topic><topic>Medial Forebrain Bundle - physiopathology</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Middle Aged</topic><topic>Neurosciences</topic><topic>Original</topic><topic>original-article</topic><topic>Patient Compliance</topic><topic>Pharmacotherapy</topic><topic>Psychiatric Status Rating Scales</topic><topic>Psychiatry</topic><topic>Severity of Illness Index</topic><topic>Telemedicine</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sani, S</creatorcontrib><creatorcontrib>Busnello, J</creatorcontrib><creatorcontrib>Kochanski, R</creatorcontrib><creatorcontrib>Cohen, Y</creatorcontrib><creatorcontrib>Gibbons, R D</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Translational psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sani, S</au><au>Busnello, J</au><au>Kochanski, R</au><au>Cohen, Y</au><au>Gibbons, R D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation</atitle><jtitle>Translational psychiatry</jtitle><stitle>Transl Psychiatry</stitle><addtitle>Transl Psychiatry</addtitle><date>2017-08-15</date><risdate>2017</risdate><volume>7</volume><issue>8</issue><spage>e1207</spage><epage>e1207</epage><pages>e1207-e1207</pages><issn>2158-3188</issn><eissn>2158-3188</eissn><abstract>Although there have been previous studies of deep-brain stimulation (DBS), we present, to our knowledge, the first example of high-frequency depressive severity measurement-based DBS treatment in particular and psychiatric treatment in general. Daily post-surgical e-mail prompts for a period of 6 months resulted in 93 administrations of a computerized adaptive test (CAT) of depression severity (CAT-Depression Inventory or CAT-DI) via the internet. There was an average of 3.37 weekly measurements with an average separation of 2.12 days. No additional incentive was provided to the patient for completing the adaptive tests. The patient is a 55-year-old female with six psychiatric hospitalizations for depression, two suicide attempts, marginal response to eight electroconvulsive therapy (ECT) treatments and 35 psychotropic medications. We report results after high-frequency stimulation of the superolateral branch of the medial forebrain bundle. The CAT-DI was used for daily assessments before, during and after (remotely in response to an e-mail prompt) the DBS procedure. Two follow-up Hamilton Depression Scales (HAM-Ds) were also collected. Response to treatment varied markedly, with a decrease from severe (>75) to mild (60), which is three times the size of the uncertainty level. Although the HAM-D scores decreased, they missed the more complete temporal pattern identified by CAT-DI daily monitoring. We demonstrated feasibility of daily depressive severity measurement at high levels of precision and compliance. Clinician ratings confirm the general pattern of treatment benefit, but mask the marked variability in mood and more marked periods of benefit and decline.</abstract><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>28809861</pmid><doi>10.1038/tp.2017.145</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2158-3188 |
ispartof | Translational psychiatry, 2017-08, Vol.7 (8), p.e1207-e1207 |
issn | 2158-3188 2158-3188 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5611718 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Springer Nature OA Free Journals; Nature Free; EZB-FREE-00999 freely available EZB journals; PubMed Central |
subjects | 631/378/340 631/443 Behavioral Sciences Biological Psychology Deep Brain Stimulation Depressive Disorder, Treatment-Resistant - diagnosis Depressive Disorder, Treatment-Resistant - therapy Electroconvulsive therapy Female Humans Medial Forebrain Bundle - physiopathology Medicine Medicine & Public Health Middle Aged Neurosciences Original original-article Patient Compliance Pharmacotherapy Psychiatric Status Rating Scales Psychiatry Severity of Illness Index Telemedicine Treatment Outcome |
title | High-frequency measurement of depressive severity in a patient treated for severe treatment-resistant depression with deep-brain stimulation |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A19%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=High-frequency%20measurement%20of%20depressive%20severity%20in%20a%20patient%20treated%20for%20severe%20treatment-resistant%20depression%20with%20deep-brain%20stimulation&rft.jtitle=Translational%20psychiatry&rft.au=Sani,%20S&rft.date=2017-08-15&rft.volume=7&rft.issue=8&rft.spage=e1207&rft.epage=e1207&rft.pages=e1207-e1207&rft.issn=2158-3188&rft.eissn=2158-3188&rft_id=info:doi/10.1038/tp.2017.145&rft_dat=%3Cproquest_pubme%3E1929886826%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1928761555&rft_id=info:pmid/28809861&rfr_iscdi=true |